About Sapphire Therapeutics
Sapphire Therapeutics was founded in 2008 and is headquartered in Iselin, United States. Focus is placed on the development of small molecule drugs targeting metabolic and oncologic disorders within the biotechnology sector. The pipeline features anamorelin in phase 2 trials for cancer cachexia, ipamorelin in phase 2 for postoperative ileus, and ST-114 in phase 1 for opioid-induced bowel dysfunction. Operations center on advancing these therapeutic candidates through clinical stages.
- Headquarter Iselin, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sapphire Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sapphire Therapeutics
Sapphire Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Helsinn. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sapphire Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sapphire Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sapphire Therapeutics Comparisons
Competitors of Sapphire Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Sapphire Therapeutics
When was Sapphire Therapeutics founded?
Sapphire Therapeutics was founded in 2008.
Where is Sapphire Therapeutics located?
Sapphire Therapeutics is headquartered in Iselin, United States. It is registered at Iselin, New Jersey, United States.
What does Sapphire Therapeutics do?
Sapphire Therapeutics was founded in 2008 and is headquartered in Iselin, United States. Focus is placed on the development of small molecule drugs targeting metabolic and oncologic disorders within the biotechnology sector. The pipeline features anamorelin in phase 2 trials for cancer cachexia, ipamorelin in phase 2 for postoperative ileus, and ST-114 in phase 1 for opioid-induced bowel dysfunction. Operations center on advancing these therapeutic candidates through clinical stages.
Who are Sapphire Therapeutics's investors?
Sapphire Therapeutics has 1 investor. Key investors include Helsinn.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.